VIDA, founded in 2004, is a clinical imaging intelligence company headquartered in Coralville, Iowa. It applies AI and quantitative imaging technology to transform drug development and clinical trials for life sciences companies, including five of the world's top ten pharmaceutical firms.
The company's core product, the VIDA Intelligence Platform, is an AI-powered system designed to streamline clinical trial imaging. It automates processes including radiology assessments, eligibility reads, safety reads, and the generation of quantitative imaging biomarkers. From a single scan, the platform can produce up to 15,000 individual metrics across more than 50 biomarkers.
With over two decades of experience in quantitative imaging, VIDA has processed more than 500,000 imaging scans. Its network spans over 1,500 certified clinical trial sites in more than 40 countries. The company's work is documented in over 700 journal papers, reflecting its deep integration into clinical research.
